Cystoscopy: Clinical Trials

6 trials of Cystoscopy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 1 not yet recruiting. 6 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Recruiting 3, Completed 2, Not yet recruiting 1
Phase 25Recruiting 3, Completed 1, Not yet recruiting 1

Follow Cystoscopy: new trials by email Literature Review of Cystoscopy trials Research Report on Cystoscopy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder Carcinoma
BCG Solution, Best Practice, Cystoscopy - Non-Muscle Invasive Bladder Carcinoma
Phase 1 / Phase 2Not yet recruitingOhio State University Comprehensive Cancer Center492027-01-152026-10-14
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Radiosensitizing Agent - Muscle Invasive Bladder Carcinoma, Stage III Bladder Cancer AJCC v8
Phase 1 / Phase 2RecruitingUniversity of Washington122026-08-202026-08-25
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
BCG Solution, Cystoscopy, Docetaxel - Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic402025-04-212026-10-08
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Enfortumab Vedotin, Pembrolizumab, Intensity Modulated Radiation Therapy (IMRT) - Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Phase 1 / Phase 2RecruitingUniversity of California, San Francisco472025-03-312026-10-01
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
Durvalumab, Vicineum, Acetaminophen - Urinary Bladder Neoplasms
Phase 1CompletedNational Cancer Institute (NCI)152018-06-072026-10-27
Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer
cisplatin, gemcitabine hydrochloride, biopsy - Bladder Cancer
Phase 1 / Phase 2CompletedInstitut du Cancer de Montpellier - Val d'Aurelle142005-06-012015-07-30

Conditions studied

Urinary Bladder Neoplasms (5)  ·  Non-Muscle Invasive Bladder Neoplasms (2)  ·  Carcinoma in Situ (1)

Sponsors

Institut du Cancer de Montpellier - Val d'Aurelle (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of California, San Francisco (1)  ·  University of Washington (1)

Countries

United States (5)  ·  France (1)

Top investigators

Cheryl T Lee, MD (1)  ·  David Azria, MD, PhD (1)  ·  Raju Chelluri, M.D. (1)  ·  T. Martin Ma, MD, PhD (1)  ·  Timothy D. Lyon, MD (1)  ·  Vadim Koshkin, MD (1)

NIH funding

UL1TR002377 (1)